$3.39
-0.01[-0.29%]
At close: Apr 17
$3.39
0[0.00%]
After Hours: 6:53PM EDT
Galectin Therapeutics
(NASDAQ:GALT)Galectin Therapeutics Stock (NASDAQ:GALT), Earnings Estimates, EPS, and Revenue
Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.160
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | AM | GALT | Q1 | -$0.19 | -$0.16 | — | — | $0.00 | — | — | — | Get Alert |
| 03/29/2024 | AM | GALT | Q4 | -$0.18 | -$0.16 | -$0.16 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 11/13/2023 | AM | GALT | Q3 | -$0.14 | -$0.16 | -$0.24 | -50.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2023 | AM | GALT | Q2 | -$0.16 | -$0.21 | -$0.15 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
| 05/15/2023 | AM | GALT | Q1 | -$0.17 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | Get Alert |
| 03/30/2023 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $0.00 | — | Get Alert |
| 11/14/2022 | AM | GALT | Q3 | -$0.14 | -$0.20 | -$0.14 | 30.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/15/2022 | AM | GALT | Q2 | -$0.15 | -$0.21 | -$0.16 | 23.81% | $0.00 | — | $0.00 | — | Get Alert |
| 05/16/2022 | AM | GALT | Q1 | -$0.11 | -$0.14 | -$0.17 | -21.43% | $0.00 | — | $0.00 | — | Get Alert |
| 03/31/2022 | AM | GALT | Q4 | -$0.13 | -$0.19 | -$0.12 | 36.84% | $0.00 | — | $0.00 | — | Get Alert |
| 11/15/2021 | AM | GALT | Q3 | -$0.10 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 08/16/2021 | AM | GALT | Q2 | -$0.11 | -$0.18 | -$0.14 | 22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 05/17/2021 | AM | GALT | Q1 | -$0.06 | -$0.17 | -$0.11 | 35.29% | $0.00 | — | $0.00 | — | Get Alert |
| 03/31/2021 | AM | GALT | Q4 | -$0.12 | -$0.17 | -$0.13 | 23.53% | $0.00 | — | $0.00 | — | Get Alert |
| 11/09/2020 | AM | GALT | Q3 | -$0.05 | -$0.14 | -$0.10 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2020 | AM | GALT | Q2 | -$0.06 | -$0.09 | -$0.11 | -22.22% | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2020 | AM | GALT | Q1 | -$0.20 | -$0.09 | -$0.06 | 33.33% | $0.00 | — | $0.00 | — | Get Alert |
| 03/16/2020 | AM | GALT | Q4 | -$0.08 | — | -$0.12 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/12/2019 | AM | GALT | Q3 | -$0.07 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics (GALT) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?
The Actual EPS was $-0.16, which hit the estimate of $-0.16.
What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.